The Effect of Silymarin on Serum Concentration of Soluble Apoptosis Markers in β-Thalassemia Major Patients Receiving Desferrioxamine
Journal Title: Journal of Advances in Medical and Pharmaceutical Sciences - Year 2015, Vol 2, Issue 2
Abstract
Background: Despite appropriate chelation therapy with desferrioxamine, iron deposition in visceral organs causes tissue damage in thalassemia major patients. Excess iron can generate reactive oxygen species (ROS) that may lead to cell death and apoptosis. Therefore, antioxidants such as plant flavonoids can be an effective treatment to reduce ROS in thalassemia patients. Aims: In this study, we aimed to investigate the serum levels of apoptosis markers in β-thalassemia major patients treated with silymarin and desferrioxamine. Study Design: This study was a randomized, double-blind, placebo controlled 6-month clinical trial Place and Duration of Study: This clinical trial was carried out at Sayed-Al-Shohada clinic of thalassemia, Isfahan University of Medical Sciences, Iran, for 6-month between August 2009 and February 2010. Methodology: The patients were randomized into two groups: one group (A) received desferrioxamine and placebo and the other group (B) received a combination of desferrioxamine and silymarin. Serum levels of soluble apoptosis markers including soluble Fas (sCD95,sFas), sCD95 ligand (sCD95L,sFasL), sTNF receptor type 1 (sTNFR1), sTRAIL and cytochrome C, were measured before and after the trial in two groups of 40 thalassemia major patients using ELISA kits. Statistical analysis was performed using SPSS 15 version for windows program; results were expressed as mean ± standard deviation (SD) and significance set at P< 0.05. Results: There was no statistically significant difference between desferrioxamine group and combined therapy group in serum concentration of apoptosis markers, except for sTNFR1 level (which decreased from 0.16±0.12 to 0.11±0.10ng/ml) in the silymarin treatment group (P<0.05). Conclusion: Our observation of decreased circulating concentrations of sTNFR1 in silymarin-treated patients may reflect anti-inflammatory activity of silymarin in β-thalassemia major. The finding that silymarin treatment had no effect on the level of soluble apoptosis marker could be an evidence for safety of silymarin treatment in thalassemia major patients. However, measuring the membrane levels of these markers is necessary to validate these results, as they are not expressed equally in different tissues.
Authors and Affiliations
Nafiseh Esmaeil, Marjan Gharagozloo, Behjat Moayedi, Milad Mirmoghtadaei, Mahdi Ghatreh Samani
Keywords
Related Articles
- EP ID EP342660
- DOI 10.9734/JAMPS/2015/12818
- Views 80
- Downloads 0
Extended Spectrum β-Lactamases among Enterobacteriaceae Isolated from Clinical Specimens of a Tertiary Hospital in 2014
Extended spectrum beta-lactamase producing Enterobacteriaceae have become widespread among hospitals and even in the community. Such phenomenon poses a therapeutic dilemma against certain antimicrobial drugs that limit t...
Synthesis of Unstable Vaterite Polymorph of Hollow Calcium Carbonate Nanoparticles and Encapsulation of the Anticancer Drug Cisplatin
Cisplatin is the first generation platinum coordination complex-based anticancer drug developed to treat many different types of cancers. However, cisplatin is associated with numerous side effects. Most of these side ef...
Chemical Evaluation, Free Radical Scavenging Activities and Antimicrobial Evaluation of the Methanolic Extracts of Corn Silk (Zea mays)
Corn silk is thought to possess medicinal properties according to Nigerian folklore. This study was undertaken to appraise its phytochemical constituents and anti-microbial activities. Data obtained revealed that alkaloi...
Assessment of National Health Insurance Scheme’s (NHIS) Effectiveness in a Tertiary Teaching Hospital in Southeast Nigeria
Background: The fundamental concept of health insurance is risk sharing and burden bearing. The scheme is undermined by limitations ranging from very frequent use of the services more than necessary by enrollees, to cost...
Optimize Diabetes by Herbal Medicine: A Review
Plant-based medicinal products have been acknowledged since ancient times and several medicinal plants and their products have been used to control diabetes in the traditional medicinal systems of many cultures worldwide...